Snipperfingers for Rehabilitation
(Snipperfinger Trial)
Trial Summary
What is the purpose of this trial?
Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can contribute to deconditioning and functional mobility deficits. This study seeks to explore the feasibility of a tool designed to promote movement through engaging gameplay that is acceptable to both clinicians and families.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Snipperfingers for rehabilitation?
The research on a patient-oriented hand rehabilitation program showed better results in terms of hand function and patient satisfaction compared to standard programs. This suggests that personalized rehabilitation approaches, like Snipperfingers, may be effective in improving hand function and overall satisfaction.12345
How does the treatment Snipperfingers differ from other treatments for hand rehabilitation?
Eligibility Criteria
This trial is for pediatric patients aged 6-17 who are able to follow simple instructions and participate in standing gameplay. They must be receiving physical therapy at Stanford Children's Hospital and medically cleared for standing and upper-body movement. It excludes those with conditions that make physical activity unsafe.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Pediatric patients engage with the Snipperfingers software platform, and movement is analyzed by the OptiTrack system
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Snipperfingers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor